Celyad Oncology S.A.
CLYYF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,700 | -$2,780 | -$3,044 | -$4,708 |
| Dep. & Amort. | $0 | $221 | $229 | $397 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | -$6 | $6 | $491 |
| Change in WC | $0 | -$483 | $306 | $2,394 |
| Other Non-Cash | $3,700 | $199 | -$328 | -$5,445 |
| Operating Cash Flow | $0 | -$2,849 | -$2,831 | -$6,871 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$118 | -$118 | -$583 |
| Net Acquisitions | $0 | $15 | $0 | $26 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $118 | $0 | -$1 |
| Investing Cash Flow | $0 | $15 | -$118 | -$558 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $83 | -$83 | $0 |
| Stock Issued | $0 | $0 | $0 | $9,490 |
| Stock Repurch. | $0 | $0 | $0 | $10 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $725 | $2,258 | -$43 |
| Financing Cash Flow | $0 | $808 | $2,175 | $9,457 |
| Forex Effect | $0 | -$4 | $0 | $0 |
| Net Chg. in Cash | $0 | -$2,029 | -$775 | $2,028 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $6,229 | $7,004 | $4,976 |
| End Cash | $0 | $4,200 | $6,229 | $7,004 |
| Free Cash Flow | $0 | -$2,849 | -$2,831 | -$7,454 |